search for   

 

Comparative Proteome Analysis of Zerumbone-treated Helicobacter pylori
Korean J Clin Lab Sci 2018;50:275-283  
Published on September 30, 2018
Copyright © 2018 Korean Society for Clinical Laboratory Science.

Sa-Hyun Kim

Department of Clinical Laboratory Science, Semyung University, Jecheon, Korea
Correspondence to: Sa-Hyun Kim
Department of Clinical Laboratory Science, Semyung University, 65 Semyeong-ro, Jecheon 27136, Korea
Tel: 82-43-649-1624
Fax: 82-50-4411-9604
E-mail: science4us@semyung.ac.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Helicobacter pylori is a causative organism of various gastrointestinal diseases, including chronic gastritis, gastric ulcer, or gastric adenocarcinoma. Pathogenic factors, such as cytotoxin-associated protein A (CagA) and vacuolating cytotoxic protein A (VacA), play a role. This study analyzed qualitatively and quantitatively the effects of zerumbone on the changes in the protein expression levels of various H. pylori proteins, including CagA and VacA. Approximately 200 significant proteins were screened for the H. pylori 60190 (VacA positive / CagA positive; Eastern type) strain, and proteomic analysis was performed on 13 protein molecules that were clinically significant. After two-dimensional electrophoresis (2-DE), ImageMasterTM 2-DE Platinum software was used for quantitative measurements of protein spots. Matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-TOF-MS) and liquid chromatography–mass spectrometry/mass spectrometry (LC-MS/MS) were used for protein identification. After intensive analysis of the proteins that showed significant changes, a reverse transcription-polymerase chain reaction was performed as required to verify the results. In this study, the significance of zerumbone as a therapeutic agent for H. pylori infection was examined by screening a new pharmacological activity mechanism of zerumbone.
Keywords : AmiE, CagA, Helicobacter pylori, OorA, VacA

September 2018, 50 (3)
Full Text(PDF) Free

Cited By Articles
  • CrossRef (0)